Chemed Gross Margin 2010-2024 | CHE

Current and historical gross margin for Chemed (CHE) over the last 10 years. The current gross profit margin for Chemed as of March 31, 2024 is %.
Chemed Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $2.29B $0.81B 35.48%
2023-12-31 $2.27B $0.80B 35.28%
2023-09-30 $2.23B $0.77B 34.50%
2023-06-30 $2.19B $0.75B 34.11%
2023-03-31 $2.16B $0.76B 35.12%
2022-12-31 $2.14B $0.77B 35.83%
2022-09-30 $2.13B $0.77B 36.31%
2022-06-30 $2.14B $0.79B 36.88%
2022-03-31 $2.14B $0.78B 36.30%
2021-12-31 $2.14B $0.77B 36.04%
2021-09-30 $2.13B $0.76B 35.85%
2021-06-30 $2.12B $0.76B 35.66%
2021-03-31 $2.09B $0.72B 34.64%
2020-12-31 $2.08B $0.70B 33.72%
2020-09-30 $2.07B $0.68B 32.79%
2020-06-30 $2.02B $0.64B 31.72%
2020-03-31 $1.99B $0.64B 32.16%
2019-12-31 $1.94B $0.62B 31.82%
2019-09-30 $1.88B $0.59B 31.31%
2019-06-30 $1.84B $0.57B 31.23%
2019-03-31 $1.81B $0.56B 31.01%
2018-12-31 $1.78B $0.56B 31.13%
2018-09-30 $1.75B $0.55B 31.20%
2018-06-30 $1.73B $0.54B 31.11%
2018-03-31 $1.70B $0.53B 31.19%
2017-12-31 $1.67B $0.52B 30.97%
2017-09-30 $1.64B $0.50B 30.65%
2017-06-30 $1.62B $0.49B 29.99%
2017-03-31 $1.59B $0.47B 29.52%
2016-12-31 $1.58B $0.46B 29.25%
2016-09-30 $1.57B $0.46B 29.26%
2016-06-30 $1.57B $0.46B 29.58%
2016-03-31 $1.56B $0.46B 29.54%
2015-12-31 $1.54B $0.46B 29.53%
2015-09-30 $1.52B $0.45B 29.46%
2015-06-30 $1.50B $0.44B 29.21%
2015-03-31 $1.47B $0.43B 29.10%
2014-12-31 $1.46B $0.42B 28.93%
2014-09-30 $1.43B $0.41B 28.63%
2014-06-30 $1.41B $0.40B 28.69%
2014-03-31 $1.41B $0.40B 28.68%
2013-12-31 $1.41B $0.41B 28.64%
2013-09-30 $1.43B $0.41B 28.52%
2013-06-30 $1.45B $0.41B 28.27%
2013-03-31 $1.44B $0.40B 27.98%
2012-12-31 $1.43B $0.40B 27.76%
2012-09-30 $1.41B $0.39B 27.78%
2012-06-30 $1.40B $0.39B 27.90%
2012-03-31 $1.38B $0.39B 28.10%
2011-12-31 $1.36B $0.39B 28.41%
2011-09-30 $1.34B $0.38B 28.64%
2011-06-30 $1.32B $0.38B 28.86%
2011-03-31 $1.30B $0.38B 29.03%
2010-12-31 $1.28B $0.38B 29.30%
2010-09-30 $1.25B $0.37B 29.35%
2010-06-30 $1.22B $0.36B 29.49%
2010-03-31 $1.20B $0.36B 29.73%
2009-12-31 $1.19B $0.36B 29.92%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.076B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00